What are the major opportunities in the Asthma Disease market? What are the strategies for the Asthma Disease market?

For detailed insights on the major opportunities and strategies in the Asthma Disease market, Read More

How does the Asthma Disease market relate to the overall economy and other similar markets?

For detailed insights on Asthma Disease's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Asthma Disease market growth? SWOT analysis of the Asthma Disease market.

For detailed insights on the key dynamics influencing the Asthma Disease market growth and SWOT analysis of the Asthma Disease industry, Read More

Asthma Disease Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Asthma Disease Market Report 2026

Name: Asthma Disease Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment Type (Controller Medications, Rescue Medications, Biologics, Combination Therapy), By Cause Of Asthma (Allergic Asthma, Non-Allergic Asthma, Exercise-Induced Asthma, Occupational Asthma), By Severity (Mild Intermittent, Mild Persistent, Moderate Persistent, Severe Persistent), By Route Of Administration (Oral, Inhaled, Intravenous, Other Route Of Administration), By End-Users (Hospitals, Homecare, Specialty Clinics , Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Asthma Disease Market Overview

• Asthma Disease market size has reached to $25.93 billion in 2025

• Expected to grow to $33.11 billion in 2030 at a compound annual growth rate (CAGR) of 5%

• Growth Driver: Rising Prevalence Of Respiratory Disorders Driving Growth Of The Market Due To Air Pollution

• Market Trend: Innovations In Smart Inhaler Technology Transform Asthma Management

• North America was the largest region in 2025.

What Is Covered Under Asthma Disease Market?

Asthma disease refers to a chronic inflammatory disorder of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early in the morning. It involves airflow obstruction that is often reversible either spontaneously or with treatment and is associated with airway hyperresponsiveness to various stimuli such as allergens, exercise, or cold air.

The main treatment types of asthma disease are controller medications, rescue medications, biologics, and combination therapy. Controller medications refer to long-term asthma management drugs that are taken daily to prevent asthma symptoms and attacks. The multiple causes of asthma are allergic asthma, non-allergic asthma, exercise-induced asthma, and occupational asthma. The various severities include mild intermittent, mild persistent, moderate persistent, and severe persistent. The several routes of administration include oral, inhaled, intravenous, and others, and are used by various end users such as hospitals, homecare, specialty clinics, and others.

Asthma Disease Market Global Report 2026 Market Report bar graph

What Is The Asthma Disease Market Size and Share 2026?

The asthma disease market size has grown strongly in recent years. It will grow from $25.93 billion in 2025 to $27.29 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to limited awareness of asthma management, reliance on rescue medications, lack of advanced biologics, insufficient homecare infrastructure, growing urban pollution levels.

What Is The Asthma Disease Market Growth Forecast?

The asthma disease market size is expected to see steady growth in the next few years. It will grow to $33.11 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to development of novel biologics and combination therapies, increasing adoption of controller medications, expansion of specialty clinics and homecare services, rising patient awareness and education programs, integration of digital health monitoring and smart inhaler technologies. Major trends in the forecast period include rising prevalence of asthma worldwide, increasing adoption of inhalation therapies, growth in biologics and targeted treatments, expansion of homecare and specialty clinics, focus on personalized and precision medicine approaches.

Book your 30 minutes free consultation with our research experts

Global Asthma Disease Market Segmentation

1) By Treatment Type: Controller Medications, Rescue Medications, Biologics, Combination Therapy

2) By Cause Of Asthma: Allergic Asthma, Non-Allergic Asthma, Exercise-Induced Asthma, Occupational Asthma

3) By Severity: Mild Intermittent, Mild Persistent, Moderate Persistent, Severe Persistent

4) By Route Of Administration: Oral, Inhaled, Intravenous, Other Route Of Administration

5) By End-Users: Hospitals, Homecare, Specialty Clinics , Other End-Users

Subsegments:

1) By Controller Medications: Inhaled Corticosteroids (ICS), Long-Acting Beta-Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Long-Acting Muscarinic Antagonists (LAMA), Methylxanthines

2) By Rescue Medications: Short-Acting Beta-Agonists (SABA), Systemic Corticosteroids, Anticholinergics

3) By Biologics: Anti-IGE Therapy, Anti-IL-5 Therapy, Anti-IL-4/IL-13 Therapy, Anti-TSLP Therapy

4) By Combination Therapy: ICS Or LABA Combinations, ICS Or LABA Or LAMA Combinations, ICS Or LAMA Combinations

What Is The Driver Of The Asthma Disease Market?

The rising prevalence of respiratory disorders is expected to propel the growth of the asthma disease market going forward. Respiratory disorders refer to a group of diseases that affect the lungs and breathing, including chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. The increasing prevalence of respiratory disorders is due to particulate matter and nitrogen oxides irritating and inflaming the airways, leading to breathing difficulties and worsening conditions such as asthma. Respiratory diseases can cause inflammation and airway remodeling, which trigger or worsen asthma symptoms. For instance, in December 2023, according to the National Library of Medicine, a US-based national library, by 2050, chronic obstructive pulmonary disease (COPD) cases in low- and middle-income countries are projected to more than double those in high-income countries, with sub-Saharan Africa expected to see a 59% increase and lead globally in COPD prevalence and cases by 2040. Therefore, the rising prevalence of respiratory disorders is driving the growth of the asthma disease industry.

Key Players In The Global Asthma Disease Market

Major companies operating in the asthma disease market are Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Cipla Limited

Global Asthma Disease Market Trends and Insights

Major companies operating in the asthma disease market are increasingly focusing on leveraging advanced solutions such as integrated bluetooth enabled sensor inhalers to enhance medication adherence, enable real time usage monitoring, and support personalized disease management. Integrated bluetooth-enabled sensor inhalers are inhalers fitted with digital sensors that sync usage information to a smartphone app, helping people with asthma by tracking medication use, improving adherence through reminders, and providing data that supports better symptom monitoring and management. For instance, in July 2023, Teva Pharmaceutical Industries Limited, an Israel based pharmaceutical company, launched the GoResp Digihaler (budesonide and formoterol) in the UK as the first fully integrated digital inhaler system for asthma disease and chronic obstructive pulmonary disease in Europe. This inhaler, manufactured in Ireland, incorporates built in sensors that detect and record inspiratory flow and usage quality and it pairs with a patient facing app that displays inhalation performance categorized as good, fair, or low or no and enables report sharing with healthcare professionals through email or a clinician dashboard. The app also provides medication reminders to help patients stay consistent with therapy while clinicians gain deeper insight into individual technique and adherence patterns, supporting more tailored interventions.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Asthma Disease Market?

In January 2024, GSK plc, a UK-based pharmaceutical company, acquired Aiolos Bio Inc. for an undisclosed amount. With this acquisition, GSK aims to strengthen its respiratory treatment portfolio and drive long-term growth by leveraging Aiolos Bio’s innovative therapies and GSK’s global reach to better serve patients worldwide. Aiolos Bio Inc. is a US-based clinical-stage biopharmaceutical company specializing in asthma treatment.

Regional Insights

North America was the largest region in the asthma disease market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Asthma Disease Market?

The asthma disease market consists of revenues earned by entities by providing services such as diagnosis, screening, allergy testing, immunotherapy, education, counselling, and medication management. The market value includes the value of related goods sold by the service provider or included within the service offering. The asthma disease market also includes sales of peak flow meters, spirometers, allergy medications, biologic drugs, air purifiers, humidifiers, smart inhalers, wearable asthma monitors, and allergen-proof bedding. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Asthma Disease Market Report 2026?

The asthma disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the asthma disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Asthma Disease Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$27.29 billion
Revenue Forecast In 2035	$33.11 billion
Growth Rate	CAGR of 5.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment Type, Cause Of Asthma, Severity, Route Of Administration, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Cipla Limited
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Asthma Disease Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Asthma Disease Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Asthma Disease Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Asthma Disease Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Rising Prevalence Of Asthma Worldwide

4.2.2 Increasing Adoption Of Inhalation Therapies

4.2.3 Growth In Biologics And Targeted Treatments

4.2.4 Expansion Of Homecare And Specialty Clinics

4.2.5 Focus On Personalized And Precision Medicine Approaches

5. Asthma Disease Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Homecare Providers

5.3 Specialty Clinics

5.4 Pharmacies

5.5 Research And Diagnostic Centers

6. Asthma Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Asthma Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Asthma Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Asthma Disease Market Size, Comparisons And Growth Rate Analysis

7.3. Global Asthma Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Asthma Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Asthma Disease Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Asthma Disease Market Segmentation

9.1. Global Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Controller Medications, Rescue Medications, Biologics, Combination Therapy

9.2. Global Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Allergic Asthma, Non-Allergic Asthma, Exercise-Induced Asthma, Occupational Asthma

9.3. Global Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mild Intermittent, Mild Persistent, Moderate Persistent, Severe Persistent

9.4. Global Asthma Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Inhaled, Intravenous, Other Route Of Administration

9.5. Global Asthma Disease Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Clinics, Others End-Users

9.6. Global Asthma Disease Market, Sub-Segmentation Of Controller Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inhaled Corticosteroids (ICS), Long-Acting Beta-Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Long-Acting Muscarinic Antagonists (LAMA), Methylxanthines

9.7. Global Asthma Disease Market, Sub-Segmentation Of Rescue Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Short-Acting Beta-Agonists (SABA), Systemic Corticosteroids, Anticholinergics

9.8. Global Asthma Disease Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-IGE Therapy, Anti-IL-5 Therapy, Anti-IL-4/IL-13 Therapy, Anti-TSLP Therapy

9.9. Global Asthma Disease Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

ICS Or LABA Combinations, ICS Or LABA Or LAMA Combinations, ICS Or LAMA Combinations

10. Asthma Disease Market Regional And Country Analysis

10.1. Global Asthma Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Asthma Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Asthma Disease Market

11.1. Asia-Pacific Asthma Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Asthma Disease Market

12.1. China Asthma Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Asthma Disease Market

13.1. India Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Asthma Disease Market

14.1. Japan Asthma Disease Market Overview

14.2. Japan Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Asthma Disease Market

15.1. Australia Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Asthma Disease Market

16.1. Indonesia Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Asthma Disease Market

17.1. South Korea Asthma Disease Market Overview

17.2. South Korea Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Asthma Disease Market

18.1. Taiwan Asthma Disease Market Overview

18.2. Taiwan Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Asthma Disease Market

19.1. South East Asia Asthma Disease Market Overview

19.2. South East Asia Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Asthma Disease Market

20.1. Western Europe Asthma Disease Market Overview

20.2. Western Europe Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Asthma Disease Market

21.1. UK Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Asthma Disease Market

22.1. Germany Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Asthma Disease Market

23.1. France Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Asthma Disease Market

24.1. Italy Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Asthma Disease Market

25.1. Spain Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Asthma Disease Market

26.1. Eastern Europe Asthma Disease Market Overview

26.2. Eastern Europe Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Asthma Disease Market

27.1. Russia Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Asthma Disease Market

28.1. North America Asthma Disease Market Overview

28.2. North America Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Asthma Disease Market

29.1. USA Asthma Disease Market Overview

29.2. USA Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Asthma Disease Market

30.1. Canada Asthma Disease Market Overview

30.2. Canada Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Asthma Disease Market

31.1. South America Asthma Disease Market Overview

31.2. South America Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Asthma Disease Market

32.1. Brazil Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Asthma Disease Market

33.1. Middle East Asthma Disease Market Overview

33.2. Middle East Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Asthma Disease Market

34.1. Africa Asthma Disease Market Overview

34.2. Africa Asthma Disease Market, Segmentation By Treatment Type, Segmentation By Cause Of Asthma, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Asthma Disease Market Regulatory and Investment Landscape

36. Asthma Disease Market Competitive Landscape And Company Profiles

36.1. Asthma Disease Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Asthma Disease Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Asthma Disease Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

37. Asthma Disease Market Other Major And Innovative Companies

GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A.

38. Global Asthma Disease Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Asthma Disease Market

40. Asthma Disease Market High Potential Countries, Segments and Strategies

40.1 Asthma Disease Market In 2030 - Countries Offering Most New Opportunities

40.2 Asthma Disease Market In 2030 - Segments Offering Most New Opportunities

40.3 Asthma Disease Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Asthma Disease Market, Overview Of Key Products - Product Examples

Table 2: Global Asthma Disease Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Asthma Disease Market, Supply Chain Analysis

Table 4: Global Asthma Disease Market, Major Raw Material Providers

Table 5: Global Asthma Disease Market, Major Resource Providers

Table 6: Global Asthma Disease Market, Major Manufacturers (Suppliers)

Table 7: Global Asthma Disease Market, Major Distributors And Channel Partners

Table 8: Global Asthma Disease Market, Key Technologies & Future Trends

Table 9: Global Asthma Disease Market, Major Trends

Table 10: Global Asthma Disease Market, Major End Users

Table 11: Global Asthma Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Asthma Disease Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Asthma Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Asthma Disease Market - TAM, US$ Billion, 2025

Table 15: Global Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Asthma Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Asthma Disease Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Asthma Disease Market, Sub-Segmentation Of Controller Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Asthma Disease Market, Sub-Segmentation Of Rescue Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Asthma Disease Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Asthma Disease Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Asthma Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Asthma Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Asthma Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Asthma Disease Market - Company Scoring Matrix

Table 100: Pfizer Inc. Financial Performance

Table 101: Merck & Co. Inc. Financial Performance

Table 102: Novartis AG Financial Performance

Table 103: Sanofi S.A. Financial Performance

Table 104: AstraZeneca PLC Financial Performance

Table 105: Global Asthma Disease Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Asthma Disease Market, Competitive Dashboard

Table 107: Global Asthma Disease Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Asthma Disease Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 109: Global, Asthma Disease Market Size Gain ($ Billion), Segmentation By Cause Of Asthma, 2025 – 2030

Table 110: Global, Asthma Disease Market Size Gain ($ Billion), Segmentation By Severity, 2025 – 2030

List Of Figures

Figure 1: Global Asthma Disease Market, Overview Of Key Products - Product Examples

Figure 2: Global Asthma Disease Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Asthma Disease Market, Supply Chain Analysis

Figure 4: Global Asthma Disease Market, Major Raw Material Providers

Figure 5: Global Asthma Disease Market, Major Resource Providers

Figure 6: Global Asthma Disease Market, Major Manufacturers (Suppliers)

Figure 7: Global Asthma Disease Market, Major Distributors And Channel Partners

Figure 8: Global Asthma Disease Market, Key Technologies & Future Trends

Figure 9: Global Asthma Disease Market, Major Trends

Figure 10: Global Asthma Disease Market, Major End Users

Figure 11: Global Asthma Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Asthma Disease Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Asthma Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Asthma Disease Market - TAM, US$ Billion, 2025

Figure 15: Global Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Asthma Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Asthma Disease Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Asthma Disease Market, Sub-Segmentation Of Controller Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Asthma Disease Market, Sub-Segmentation Of Rescue Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Asthma Disease Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Asthma Disease Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Asthma Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Asthma Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Asthma Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Asthma Disease Market - Company Scoring Matrix

Figure 100: Pfizer Inc. Financial Performance

Figure 101: Merck & Co. Inc. Financial Performance

Figure 102: Novartis AG Financial Performance

Figure 103: Sanofi S.A. Financial Performance

Figure 104: AstraZeneca PLC Financial Performance

Figure 105: Global Asthma Disease Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Asthma Disease Market, Competitive Dashboard

Figure 107: Global Asthma Disease Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Asthma Disease Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 109: Global, Asthma Disease Market Size Gain ($ Billion), Segmentation By Cause Of Asthma, 2025 – 2030

Figure 110: Global, Asthma Disease Market Size Gain ($ Billion), Segmentation By Severity, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report 2026 - Global Outlook – By Type (Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other...

Black Lung Disease Market Report 2026 - Global Outlook – By Type (Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis), By Treatment (Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell ...

Allergic Rhinitis Market Report 2026 - Global Outlook – By Type (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Corticosteroids, Immunotherapy, Dec...

Intelligent Asthma Monitoring Devices Market Report 2026 - Global Outlook – By Product (Wearable Asthma Monitoring Devices, Smart Inhalers), By Distribution Channel (Retail Pharmacies, Online Pharmacies), By End User (Ho...

Asthma Drugs Market Report 2026 - Global Outlook – By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational A...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Frequently Asked Questions

How big is the Asthma Disease Market?

The Asthma Disease market was valued at $25.93 billion in 2025, increased to $27.29 billion in 2026, and is projected to reach $33.11 billion by 2030.

What is the Asthma Disease market growth?

The global Asthma Disease market is expected to grow at a CAGR of 5.0% from 2026 to 2035 to reach $33.11 billion by 2035.

Who are the key players in Asthma Disease market?

Some Key Players in the Asthma Disease market Include, Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Cipla Limited .

What is the anticipated growth trend for the Asthma Disease market?

Major trend in this market includes: Innovations In Smart Inhaler Technology Transform Asthma Management. For further insights on this market. request a sample here

Which region has the most growth potential in the Asthma Disease market?

North America was the largest region in the asthma disease market in 2025. The regions covered in the asthma disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.